KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $265 | -24.7% | 11,530 | -2.9% | 0.02% | -19.2% |
| Q1 2023 | $352 | +24.8% | 11,870 | +5.1% | 0.03% | +13.0% |
| Q4 2022 | $282 | -99.9% | 11,292 | -8.5% | 0.02% | -8.0% |
| Q3 2022 | $269,000 | -20.9% | 12,342 | -28.4% | 0.02% | -19.4% |
| Q2 2022 | $340,000 | +28.8% | 17,243 | +176.9% | 0.03% | +244.4% |
| Q1 2022 | $264,000 | +32.0% | 6,228 | +97.7% | 0.01% | +28.6% |
| Q4 2021 | $200,000 | – | 3,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |